Skip to content
value.today

IsoPlexis Corp

🇺🇸 New Haven, Connecticut, USABiotechnologyFounded 2013
Total raised
$119 M
6 rounds on record
Latest round
$85 M
Dec 2020
First round on record
Jul 2014
Today
Private
No later event on record

Funding rounds

6 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of IsoPlexis Corp
MonthRaisedRaiseSizeInvestorsSoldFiling
Dec 2020$85 MNo. 6$50 to $250 million

IsoPlexis Corp: Raise no. 6, Dec 2020

Investors in this round

10 investors had bought by the notice of Jan 8, 2021: 10 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 16 investors are named for IsoPlexis Corp as a whole in other filings: see Investors below.

What the notice says

Amount sold
$85 M of $85 M offered
Smallest investment taken
no minimum stated
What was sold
equity, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks payments to its own people as estimates
The company
Corporation, incorporated in Delaware

People named in the notice

  • John Strahley · Executive Officer
  • Sean Mackay · Executive Officer, Director
  • Daniel Wagner · Director
  • Gregory Ho · Director
  • James Heath · Director
  • John Conley · Director
  • Michael Egholm · Director
  • Sharon Kedar · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Sean Mackay, CEO and President. Source: SEC Form D and 1 amendment, newest notice filed Jan 8, 2021. Read the notice at the SEC.

equity, optionsSEC
Nov 2018$20 MNo. 5$10 to $50 million

IsoPlexis Corp: Raise no. 5, Nov 2018

Investors in this round

6 investors had bought by the notice of Nov 14, 2018: 6 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 16 investors are named for IsoPlexis Corp as a whole in other filings: see Investors below.

What the notice says

Amount sold
$20 M of $25 M offered; $5 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks payments to its own people as estimates
The company
Corporation, incorporated in Delaware

People named in the notice

  • Sean Mackay · Executive Officer, Director
  • Daniel Wagner · Director
  • Gregory Ho · Director
  • James Heath · Director
  • John Conley · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Sean Mackay, CEO and President. Source: SEC Form D, newest notice filed Nov 14, 2018. Read the notice at the SEC.

equity, optionsSEC
Jul 2017$5 MNo. 4$2 to $10 million

IsoPlexis Corp: Raise no. 4, Jul 2017

Investors in this round

4 investors had bought by the notice of Aug 10, 2017: 4 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 16 investors are named for IsoPlexis Corp as a whole in other filings: see Investors below.

What the notice says

Amount sold
$5 M of $6 M offered; $1 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks payments to its own people as estimates
The company
Corporation, incorporated in Delaware

People named in the notice

  • Sean Mackay · Executive Officer, Director
  • Daniel Wagner · Director
  • Gregory Ho · Director
  • James Heath · Director
  • John Conley · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Sean Mackay, President. Source: SEC Form D, newest notice filed Aug 10, 2017. Read the notice at the SEC.

equity, optionsSEC
Jun 2016$6 MNo. 3$2 to $10 million

IsoPlexis Corp: Raise no. 3, Jun 2016

Investors in this round

5 investors had bought by the notice of Jun 29, 2016: 5 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 16 investors are named for IsoPlexis Corp as a whole in other filings: see Investors below.

What the notice says

Amount sold
$6 M of $8 M offered; $2 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks payments to its own people as estimates
The company
Corporation, incorporated in Delaware

People named in the notice

  • Sean McKay · Executive Officer, Director
  • Daniel Wagner · Director
  • Gregory Ho · Director
  • James Heath · Director
  • Rong Fan · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Sean McKay, Chief Executive Officer. Source: SEC Form D, newest notice filed Jun 29, 2016. Read the notice at the SEC.

equity, optionsSEC
May 2015$2 MNo. 2$2 to $10 million

IsoPlexis Corp: Raise no. 2, May 2015

Investors in this round

4 investors had bought by the notice of May 29, 2015: 4 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 16 investors are named for IsoPlexis Corp as a whole in other filings: see Investors below.

What the notice says

Amount sold
$2 M of $4 M offered; $2 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks payments to its own people as estimates
The company
Corporation, incorporated in Delaware

People named in the notice

  • Sean McKay · Executive Officer, Director
  • Daniel Wagner · Director
  • Gregory Ho · Director
  • John Conley · Director
  • Rong Fan · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Sean McKay, President. Source: SEC Form D, newest notice filed May 29, 2015. Read the notice at the SEC.

equitySEC
Jul 2014$1 MNo. 1Under $2 million

IsoPlexis Corp: Raise no. 1, Jul 2014

Investors in this round

7 investors had bought by the notice of Jul 29, 2014: 7 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 16 investors are named for IsoPlexis Corp as a whole in other filings: see Investors below.

What the notice says

Amount sold
$1 M of $2 M offered; $0 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks payments to its own people as estimates
The company
Corporation, incorporated in Delaware

People named in the notice

  • Sean Mackay · Executive Officer, Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Sean Mackay, President. Source: SEC Form D, newest notice filed Jul 29, 2014. Read the notice at the SEC.

equitySEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • IsoPlexis Corp chose not to state its revenue in its newest notice of a funding round (Jan 2021).

    SEC Form D · Jan 2021

  • The industry group it chose in its notices: Biotechnology.

    SEC Form D · Jan 2021

That is all the official record says: IsoPlexis Corp has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

16 named in official filings. Open an investor to see everything it has backed.

Investors in IsoPlexis Corp
InvestorKindAmountRoundRoleSource
Northpond Capital GP, LLCFund or asset managernot statednot statedHeld Series C, C-2 and D preferred stock, 10% owner (Form 3, 2021)SEC Form 3
Northpond Capital, L.P.Fund or asset managernot statednot statedHeld Series C, C-2 and D preferred stock, 10% owner (Form 3, 2021)SEC Form 3
Northpond Ventures GP, LLCVenture capitalnot statednot statedHeld Series C, C-2 and D preferred stock, 10% owner (Form 3, 2021)SEC Form 3
Northpond Ventures, LPVenture capitalnot statednot statedHeld Series C, C-2 and D preferred stock, 10% owner (Form 3, 2021)SEC Form 3
Pcof Eq Aiv III, LPFund or asset managernot statednot statedHeld Series D preferred stock, 10% owner (Form 3, 2021)SEC Form 3
Perceptive Advisors LLCFund or asset managernot statednot statedHeld Series D preferred stock, 10% owner (Form 3, 2021)SEC Form 3
Perceptive Credit Advisors, LLCFund or asset managernot statednot statedHeld Series D preferred stock, 10% owner (Form 3, 2021)SEC Form 3
Perceptive Credit Holdings III, LPFund or asset managernot statednot statedHeld Series D preferred stock, 10% owner (Form 3, 2021)SEC Form 3
Perceptive Life Sciences Master Fund LTDFund or asset managernot statednot statedHeld Series D preferred stock, 10% owner (Form 3, 2021)SEC Form 3
SMC Growth Capital II GP, LLCFund or asset managernot statednot statedHeld Series A, A-2, B, B-2, C and C-2 preferred stock, 10% owner (Form 3, 2021)SEC Form 3
SMC Growth Capital Partners II, LPFund or asset managernot statednot statedHeld Series A, A-2, B, B-2, C and C-2 preferred stock, 10% owner (Form 3, 2021)SEC Form 3
SMC Holdings II G.P., LLCOthernot statednot statedHeld Series A, A-2, B, B-2, C and C-2 preferred stock, 10% owner (Form 3, 2021)SEC Form 3
SMC Holdings II, LPFund or asset managernot statednot statedHeld Series A, A-2, B, B-2, C and C-2 preferred stock, 10% owner (Form 3, 2021)SEC Form 3
SMC Private Equity Holdings GP, LLCPrivate equitynot statednot statedHeld Series A, A-2, B, B-2, C and C-2 preferred stock, 10% owner (Form 3, 2021)SEC Form 3
SMC Private Equity Holdings, LPPrivate equitynot statednot statedHeld Series A, A-2, B, B-2, C and C-2 preferred stock, 10% owner (Form 3, 2021)SEC Form 3
Spring Mountain Capital G.P., LLCFund or asset managernot statednot statedHeld Series A, A-2, B, B-2, C and C-2 preferred stock, 10% owner (Form 3, 2021)SEC Form 3

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 6 rounds above had up to 10 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by IsoPlexis Corp
NameRoleNamed in
John StrahleyExecutive officerJan 2021
Sean MackayExecutive officerJan 2021
Sean McKayExecutive officerJun 2016
Daniel WagnerDirectorJan 2021
Gregory HoDirectorJan 2021
James HeathDirectorJan 2021
John ConleyDirectorJan 2021
Michael EgholmDirectorJan 2021
Sean MackayDirectorJan 2021
Sharon KedarDirectorJan 2021
Rong FanDirectorJun 2016
Sean McKayDirectorJun 2016